Success Predictors of Adjuvant Chemotherapy in Node-Negative Breast Cancer Patients Under 55 years(1)

Background: Adjuvant systemic chemotherapy (ASCT) in lymph node-negative breast (LN−) cancers improves survival. The majority of (LN−) patients receive ASCT when the St. Gallen criteria or its modifications are used, as accurate identifiers which patients benefit from ASCT are lacking. This may impl...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Emiel A. M., van Diest, Paul J., Søiland, Håvard, Gudlaugson, Einar, Nysted, Arne, Voorhorst, Feja J., Vermorken, Jan B., Søreide, Jon-Arne, Baak, Jan P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2006
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617792/
https://www.ncbi.nlm.nih.gov/pubmed/17167182
http://dx.doi.org/10.1155/2006/152341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617792/
https://www.ncbi.nlm.nih.gov/pubmed/17167182
http://dx.doi.org/10.1155/2006/152341

Ejemplares similares